Share Price and Basic Stock Data
Last Updated: January 2, 2026, 8:10 pm
| PEG Ratio | -2.13 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ponni Sugars (Erode) Ltd operates within the sugar industry, a sector characterized by volatility in pricing and production. The company reported sales of ₹435 Cr for the year ending March 2023, a notable increase from ₹288 Cr in the previous fiscal year, indicating a robust growth trajectory. However, the sales figures for the subsequent year (March 2024) declined slightly to ₹421 Cr, followed by a projected drop to ₹359 Cr for March 2025. This fluctuation reflects the cyclical nature of the sugar market and the challenges in maintaining consistent revenue streams. Quarterly sales data from September 2022 to September 2023 shows variability, with the highest quarterly sales recorded at ₹150 Cr in September 2022 and a decline to ₹98 Cr by June 2023, before rebounding to ₹128 Cr in September 2023. The company’s ability to navigate these ups and downs will be critical for sustaining growth and profitability in the future.
Profitability and Efficiency Metrics
Ponni Sugars reported a net profit of ₹38 Cr for the fiscal year ending March 2023, up from ₹29 Cr in the previous year, demonstrating a positive trend in profitability. However, the net profit for March 2024 is projected to decline to ₹19 Cr, indicating potential challenges ahead. The operating profit margin (OPM) for the same period stood at 9%, slightly lower than the industry average, suggesting room for improvement in cost management. The interest coverage ratio (ICR) was exceptionally high at 763.40x, indicating that the company is free from debt, which enhances its financial stability. The cash conversion cycle (CCC) was reported at 192 days, reflecting inefficiencies in inventory management and receivables that could impact liquidity. Overall, while profitability metrics show strength, efficiency ratios indicate areas that require attention for better operational performance.
Balance Sheet Strength and Financial Ratios
Ponni Sugars maintains a strong balance sheet with no borrowings reported, positioning it favorably against competitors that may carry significant debt. The company’s total reserves stood at ₹528 Cr, providing a solid buffer for future investments and operational needs. The price-to-book value (P/BV) ratio was reported at 0.49x, indicating that the stock is trading below its book value, which might attract value investors. The current ratio of 6.28x suggests that the company has ample liquidity to cover its short-term liabilities, a strong indicator of financial health. On the other hand, the return on equity (ROE) was relatively low at 3.56%, which could deter potential investors seeking higher returns. The return on capital employed (ROCE) also stood at 5.18%, reflecting underutilization of capital, which could be an area for management to address to enhance shareholder value.
Shareholding Pattern and Investor Confidence
The shareholding structure of Ponni Sugars is characterized by significant promoter ownership at 47.34%, which indicates strong management control and alignment with shareholder interests. Foreign institutional investors (FIIs) hold a 9.46% stake, a decrease from earlier periods, which may reflect cautious sentiment among foreign investors. Domestic institutional investors (DIIs) hold only 0.93%, showing limited interest from institutional players. The public holds 42.27%, comprising a significant portion of the shareholder base. The number of shareholders has decreased to 18,011, down from a peak of 18,456 in June 2024, suggesting potential investor fatigue or consolidation among shareholders. This shift in the shareholding pattern may impact investor confidence, as a decline in public interest could lead to reduced market liquidity and price volatility.
Outlook, Risks, and Final Insight
The outlook for Ponni Sugars appears mixed, with strengths in its debt-free status and strong liquidity position balanced against profitability and efficiency challenges. Key risks include fluctuating sugar prices and operational inefficiencies, as evidenced by the high cash conversion cycle and declining profit projections. The company’s ability to manage inventory and receivables effectively will be crucial in mitigating these risks. Furthermore, the potential for increased sugar production in India could lead to oversupply, affecting price stability. Should the company enhance its operational efficiencies and capitalize on market opportunities, it could strengthen its competitive positioning. Conversely, failure to address these challenges may hinder growth and investor sentiment, impacting its market performance in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 75.6 Cr. | 10.2 | 16.7/7.02 | 270 | 16.8 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 84.6 Cr. | 96.9 | 123/82.0 | 21.5 | 45.3 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 536 Cr. | 80.3 | 120/57.3 | 313 | 145 | 1.56 % | 3.97 % | 1.56 % | 10.0 |
| DCM Shriram Industries Ltd | 693 Cr. | 54.5 | 63.1/44.9 | 11.4 | 105 | 3.67 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 538 Cr. | 3.76 | 12.4/3.03 | 42.5 | 3.52 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,757.04 Cr | 260.25 | 43.89 | 225.56 | 0.76% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 150 | 102 | 99 | 98 | 128 | 124 | 71 | 55 | 95 | 116 | 94 | 60 | 114 |
| Expenses | 130 | 93 | 89 | 98 | 110 | 110 | 61 | 57 | 82 | 112 | 83 | 69 | 96 |
| Operating Profit | 19 | 9 | 11 | 0 | 18 | 15 | 10 | -2 | 13 | 4 | 12 | -9 | 17 |
| OPM % | 13% | 9% | 11% | 0% | 14% | 12% | 14% | -4% | 13% | 4% | 13% | -14% | 15% |
| Other Income | 8 | 1 | 2 | 10 | 2 | 2 | 4 | 6 | 4 | 1 | 2 | 8 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| Profit before tax | 26 | 9 | 10 | 8 | 18 | 15 | 12 | 1 | 14 | 3 | 11 | -3 | 17 |
| Tax % | 16% | 15% | 34% | 13% | 16% | 21% | -16% | 13% | 16% | 8% | 58% | -15% | 15% |
| Net Profit | 22 | 8 | 7 | 7 | 15 | 12 | 14 | 1 | 12 | 2 | 5 | -3 | 15 |
| EPS in Rs | 25.27 | 8.86 | 7.94 | 7.75 | 17.43 | 13.55 | 15.77 | 0.94 | 13.41 | 2.80 | 5.27 | -3.12 | 16.93 |
Last Updated: December 29, 2025, 2:07 pm
Below is a detailed analysis of the quarterly data for Ponni Sugars (Erode) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 114.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Jun 2025) to 114.00 Cr., marking an increase of 54.00 Cr..
- For Expenses, as of Sep 2025, the value is 96.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 69.00 Cr. (Jun 2025) to 96.00 Cr., marking an increase of 27.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from -9.00 Cr. (Jun 2025) to 17.00 Cr., marking an increase of 26.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from -14.00% (Jun 2025) to 15.00%, marking an increase of 29.00%.
- For Other Income, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Jun 2025) to 2.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Jun 2025) to 17.00 Cr., marking an increase of 20.00 Cr..
- For Tax %, as of Sep 2025, the value is 15.00%. The value appears to be increasing, which may not be favorable. It has increased from -15.00% (Jun 2025) to 15.00%, marking an increase of 30.00%.
- For Net Profit, as of Sep 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Jun 2025) to 15.00 Cr., marking an increase of 18.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 16.93. The value appears strong and on an upward trend. It has increased from -3.12 (Jun 2025) to 16.93, marking an increase of 20.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:49 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 169 | 160 | 169 | 251 | 196 | 185 | 310 | 256 | 288 | 435 | 421 | 359 | 384 |
| Expenses | 170 | 165 | 168 | 213 | 175 | 165 | 269 | 226 | 253 | 395 | 378 | 333 | 360 |
| Operating Profit | -1 | -5 | 2 | 38 | 21 | 20 | 41 | 30 | 36 | 40 | 43 | 26 | 25 |
| OPM % | -1% | -3% | 1% | 15% | 11% | 11% | 13% | 12% | 12% | 9% | 10% | 7% | 6% |
| Other Income | 8 | 11 | 12 | -6 | -9 | 2 | 5 | 6 | 7 | 15 | 18 | 12 | 13 |
| Interest | 7 | 5 | 6 | 5 | 2 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 6 | 8 | 9 | 10 | 11 |
| Profit before tax | -3 | -5 | 3 | 22 | 4 | 12 | 36 | 29 | 36 | 48 | 52 | 28 | 27 |
| Tax % | 70% | -33% | 27% | 28% | 12% | 30% | 14% | 10% | 19% | 19% | 10% | 31% | |
| Net Profit | -5 | -4 | 2 | 16 | 3 | 8 | 31 | 26 | 29 | 38 | 47 | 19 | 19 |
| EPS in Rs | -5.56 | -4.24 | 2.21 | 18.52 | 3.88 | 9.80 | 35.98 | 29.84 | 34.02 | 44.59 | 54.50 | 22.42 | 21.88 |
| Dividend Payout % | -11% | 0% | 54% | 14% | 26% | 20% | 11% | 17% | 16% | 15% | 13% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 20.00% | 150.00% | 700.00% | -81.25% | 166.67% | 287.50% | -16.13% | 11.54% | 31.03% | 23.68% | -59.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | 130.00% | 550.00% | -781.25% | 247.92% | 120.83% | -303.63% | 27.67% | 19.50% | -7.35% | -83.26% |
Ponni Sugars (Erode) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 3% |
| 3 Years: | 8% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | -9% |
| 3 Years: | -13% |
| TTM: | -73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 14% |
| 3 Years: | 4% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 8% |
| 3 Years: | 7% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 12:25 pm
Balance Sheet
Last Updated: December 4, 2025, 1:48 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 115 | 112 | 113 | 248 | 264 | 284 | 239 | 318 | 360 | 444 | 543 | 524 | 528 |
| Borrowings | 83 | 78 | 77 | 49 | 7 | 35 | 20 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 45 | 51 | 50 | 32 | 48 | 63 | 48 | 50 | 50 | 62 | 53 | 48 | 52 |
| Total Liabilities | 252 | 249 | 249 | 338 | 328 | 391 | 315 | 376 | 419 | 515 | 605 | 580 | 588 |
| Fixed Assets | 133 | 128 | 123 | 118 | 120 | 114 | 109 | 104 | 112 | 118 | 123 | 130 | 136 |
| CWIP | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 | 2 | 11 | 6 |
| Investments | 21 | 21 | 21 | 141 | 156 | 169 | 95 | 151 | 170 | 225 | 290 | 255 | 249 |
| Other Assets | 97 | 100 | 105 | 79 | 53 | 108 | 111 | 120 | 133 | 170 | 189 | 183 | 197 |
| Total Assets | 252 | 249 | 249 | 338 | 328 | 391 | 315 | 376 | 419 | 515 | 605 | 580 | 588 |
Below is a detailed analysis of the balance sheet data for Ponni Sugars (Erode) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Reserves, as of Sep 2025, the value is 528.00 Cr.. The value appears strong and on an upward trend. It has increased from 524.00 Cr. (Mar 2025) to 528.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 52.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 48.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 4.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 588.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 580.00 Cr. (Mar 2025) to 588.00 Cr., marking an increase of 8.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 136.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2025) to 136.00 Cr., marking an increase of 6.00 Cr..
- For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 5.00 Cr..
- For Investments, as of Sep 2025, the value is 249.00 Cr.. The value appears to be declining and may need further review. It has decreased from 255.00 Cr. (Mar 2025) to 249.00 Cr., marking a decrease of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 197.00 Cr.. The value appears strong and on an upward trend. It has increased from 183.00 Cr. (Mar 2025) to 197.00 Cr., marking an increase of 14.00 Cr..
- For Total Assets, as of Sep 2025, the value is 588.00 Cr.. The value appears strong and on an upward trend. It has increased from 580.00 Cr. (Mar 2025) to 588.00 Cr., marking an increase of 8.00 Cr..
Notably, the Reserves (528.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -84.00 | -83.00 | -75.00 | -11.00 | 14.00 | -15.00 | 21.00 | 30.00 | 36.00 | 40.00 | 43.00 | 26.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 34 | 61 | 35 | 34 | 75 | 82 | 58 | 57 | 19 | 29 | 31 |
| Inventory Days | 225 | 226 | 177 | 113 | 93 | 243 | 69 | 111 | 143 | 107 | 122 | 187 |
| Days Payable | 79 | 99 | 85 | 34 | 109 | 138 | 51 | 76 | 66 | 48 | 30 | 26 |
| Cash Conversion Cycle | 171 | 162 | 153 | 114 | 18 | 180 | 100 | 93 | 135 | 78 | 121 | 192 |
| Working Capital Days | 39 | 27 | 37 | 41 | 5 | 29 | 64 | 77 | 104 | 54 | 84 | 125 |
| ROCE % | -1% | -5% | -1% | 13% | 6% | 6% | 13% | 10% | 10% | 12% | 10% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 22.42 | 54.49 | 44.58 | 34.01 | 29.84 |
| Diluted EPS (Rs.) | 22.42 | 54.49 | 44.58 | 34.01 | 29.84 |
| Cash EPS (Rs.) | 34.14 | 64.62 | 53.40 | 41.50 | 38.34 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 618.76 | 641.77 | 526.62 | 428.46 | 379.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 618.76 | 641.77 | 526.62 | 428.46 | 379.55 |
| Dividend / Share (Rs.) | 3.00 | 7.00 | 6.50 | 5.50 | 5.00 |
| Revenue From Operations / Share (Rs.) | 417.98 | 489.89 | 506.31 | 335.29 | 297.94 |
| PBDIT / Share (Rs.) | 44.38 | 70.62 | 64.59 | 49.45 | 42.37 |
| PBIT / Share (Rs.) | 32.66 | 60.49 | 55.78 | 41.97 | 33.87 |
| PBT / Share (Rs.) | 32.60 | 60.34 | 55.37 | 41.83 | 33.24 |
| Net Profit / Share (Rs.) | 22.42 | 54.49 | 44.58 | 34.01 | 29.84 |
| PBDIT Margin (%) | 10.61 | 14.41 | 12.75 | 14.74 | 14.22 |
| PBIT Margin (%) | 7.81 | 12.34 | 11.01 | 12.51 | 11.36 |
| PBT Margin (%) | 7.80 | 12.31 | 10.93 | 12.47 | 11.15 |
| Net Profit Margin (%) | 5.36 | 11.12 | 8.80 | 10.14 | 10.01 |
| Return on Networth / Equity (%) | 3.62 | 8.49 | 8.46 | 7.93 | 7.86 |
| Return on Capital Employeed (%) | 5.09 | 9.13 | 10.28 | 9.53 | 8.75 |
| Return On Assets (%) | 3.32 | 7.74 | 7.45 | 6.98 | 6.82 |
| Asset Turnover Ratio (%) | 0.60 | 0.75 | 0.93 | 0.72 | 0.74 |
| Current Ratio (X) | 6.28 | 4.89 | 3.00 | 3.29 | 2.77 |
| Quick Ratio (X) | 2.23 | 2.27 | 1.28 | 1.52 | 1.57 |
| Inventory Turnover Ratio (X) | 3.46 | 3.84 | 4.62 | 3.76 | 4.63 |
| Dividend Payout Ratio (NP) (%) | 31.22 | 11.92 | 12.33 | 14.70 | 13.40 |
| Dividend Payout Ratio (CP) (%) | 20.50 | 10.05 | 10.30 | 12.04 | 10.43 |
| Earning Retention Ratio (%) | 68.78 | 88.08 | 87.67 | 85.30 | 86.60 |
| Cash Earning Retention Ratio (%) | 79.50 | 89.95 | 89.70 | 87.96 | 89.57 |
| Interest Coverage Ratio (X) | 763.40 | 467.15 | 158.71 | 354.42 | 67.48 |
| Interest Coverage Ratio (Post Tax) (X) | 386.60 | 361.46 | 110.54 | 244.75 | 48.52 |
| Enterprise Value (Cr.) | 234.37 | 304.61 | 308.56 | 188.34 | 104.64 |
| EV / Net Operating Revenue (X) | 0.65 | 0.72 | 0.70 | 0.65 | 0.40 |
| EV / EBITDA (X) | 6.14 | 5.02 | 5.55 | 4.43 | 2.87 |
| MarketCap / Net Operating Revenue (X) | 0.72 | 0.82 | 0.78 | 0.68 | 0.49 |
| Retention Ratios (%) | 68.77 | 88.07 | 87.66 | 85.29 | 86.59 |
| Price / BV (X) | 0.49 | 0.62 | 0.75 | 0.53 | 0.38 |
| Price / Net Operating Revenue (X) | 0.72 | 0.82 | 0.78 | 0.68 | 0.49 |
| EarningsYield | 0.07 | 0.13 | 0.11 | 0.14 | 0.20 |
After reviewing the key financial ratios for Ponni Sugars (Erode) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.42. This value is within the healthy range. It has decreased from 54.49 (Mar 24) to 22.42, marking a decrease of 32.07.
- For Diluted EPS (Rs.), as of Mar 25, the value is 22.42. This value is within the healthy range. It has decreased from 54.49 (Mar 24) to 22.42, marking a decrease of 32.07.
- For Cash EPS (Rs.), as of Mar 25, the value is 34.14. This value is within the healthy range. It has decreased from 64.62 (Mar 24) to 34.14, marking a decrease of 30.48.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 618.76. It has decreased from 641.77 (Mar 24) to 618.76, marking a decrease of 23.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 618.76. It has decreased from 641.77 (Mar 24) to 618.76, marking a decrease of 23.01.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. It has decreased from 7.00 (Mar 24) to 3.00, marking a decrease of 4.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 417.98. It has decreased from 489.89 (Mar 24) to 417.98, marking a decrease of 71.91.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 44.38. This value is within the healthy range. It has decreased from 70.62 (Mar 24) to 44.38, marking a decrease of 26.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 32.66. This value is within the healthy range. It has decreased from 60.49 (Mar 24) to 32.66, marking a decrease of 27.83.
- For PBT / Share (Rs.), as of Mar 25, the value is 32.60. This value is within the healthy range. It has decreased from 60.34 (Mar 24) to 32.60, marking a decrease of 27.74.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 22.42. This value is within the healthy range. It has decreased from 54.49 (Mar 24) to 22.42, marking a decrease of 32.07.
- For PBDIT Margin (%), as of Mar 25, the value is 10.61. This value is within the healthy range. It has decreased from 14.41 (Mar 24) to 10.61, marking a decrease of 3.80.
- For PBIT Margin (%), as of Mar 25, the value is 7.81. This value is below the healthy minimum of 10. It has decreased from 12.34 (Mar 24) to 7.81, marking a decrease of 4.53.
- For PBT Margin (%), as of Mar 25, the value is 7.80. This value is below the healthy minimum of 10. It has decreased from 12.31 (Mar 24) to 7.80, marking a decrease of 4.51.
- For Net Profit Margin (%), as of Mar 25, the value is 5.36. This value is within the healthy range. It has decreased from 11.12 (Mar 24) to 5.36, marking a decrease of 5.76.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 15. It has decreased from 8.49 (Mar 24) to 3.62, marking a decrease of 4.87.
- For Return on Capital Employeed (%), as of Mar 25, the value is 5.09. This value is below the healthy minimum of 10. It has decreased from 9.13 (Mar 24) to 5.09, marking a decrease of 4.04.
- For Return On Assets (%), as of Mar 25, the value is 3.32. This value is below the healthy minimum of 5. It has decreased from 7.74 (Mar 24) to 3.32, marking a decrease of 4.42.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.60. It has decreased from 0.75 (Mar 24) to 0.60, marking a decrease of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 6.28. This value exceeds the healthy maximum of 3. It has increased from 4.89 (Mar 24) to 6.28, marking an increase of 1.39.
- For Quick Ratio (X), as of Mar 25, the value is 2.23. This value exceeds the healthy maximum of 2. It has decreased from 2.27 (Mar 24) to 2.23, marking a decrease of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.46. This value is below the healthy minimum of 4. It has decreased from 3.84 (Mar 24) to 3.46, marking a decrease of 0.38.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.22. This value is within the healthy range. It has increased from 11.92 (Mar 24) to 31.22, marking an increase of 19.30.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 20.50. This value is within the healthy range. It has increased from 10.05 (Mar 24) to 20.50, marking an increase of 10.45.
- For Earning Retention Ratio (%), as of Mar 25, the value is 68.78. This value is within the healthy range. It has decreased from 88.08 (Mar 24) to 68.78, marking a decrease of 19.30.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 79.50. This value exceeds the healthy maximum of 70. It has decreased from 89.95 (Mar 24) to 79.50, marking a decrease of 10.45.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 763.40. This value is within the healthy range. It has increased from 467.15 (Mar 24) to 763.40, marking an increase of 296.25.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 386.60. This value is within the healthy range. It has increased from 361.46 (Mar 24) to 386.60, marking an increase of 25.14.
- For Enterprise Value (Cr.), as of Mar 25, the value is 234.37. It has decreased from 304.61 (Mar 24) to 234.37, marking a decrease of 70.24.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.65, marking a decrease of 0.07.
- For EV / EBITDA (X), as of Mar 25, the value is 6.14. This value is within the healthy range. It has increased from 5.02 (Mar 24) to 6.14, marking an increase of 1.12.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.72, marking a decrease of 0.10.
- For Retention Ratios (%), as of Mar 25, the value is 68.77. This value is within the healthy range. It has decreased from 88.07 (Mar 24) to 68.77, marking a decrease of 19.30.
- For Price / BV (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.62 (Mar 24) to 0.49, marking a decrease of 0.13.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.72, marking a decrease of 0.10.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to 0.07, marking a decrease of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ponni Sugars (Erode) Ltd:
- Net Profit Margin: 5.36%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.09% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.62% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 386.6
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.23
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18 (Industry average Stock P/E: 43.89)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.36%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | Esvin House, Chennai (Madras) Tamil Nadu 600096 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. N Ramanathan | Managing Director |
| Mr. Chellamani Naresh | Director |
| Mr. Mohan Verghese Chunkath | Director |
| Mr. Bharti Chhotubhai Pithawalla | Director |
| Mr. P Manoharan | Director |
| Mr. Arun G Bijur | Director |
| Dr. Lakshmi Nadkarni | Director |
| Mr. N Gopala Ratnam | Chairman |
FAQ
What is the intrinsic value of Ponni Sugars (Erode) Ltd?
Ponni Sugars (Erode) Ltd's intrinsic value (as of 02 January 2026) is ₹323.53 which is 22.55% higher the current market price of ₹264.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹227 Cr. market cap, FY2025-2026 high/low of ₹419/261, reserves of ₹528 Cr, and liabilities of ₹588 Cr.
What is the Market Cap of Ponni Sugars (Erode) Ltd?
The Market Cap of Ponni Sugars (Erode) Ltd is 227 Cr..
What is the current Stock Price of Ponni Sugars (Erode) Ltd as on 02 January 2026?
The current stock price of Ponni Sugars (Erode) Ltd as on 02 January 2026 is ₹264.
What is the High / Low of Ponni Sugars (Erode) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ponni Sugars (Erode) Ltd stocks is ₹419/261.
What is the Stock P/E of Ponni Sugars (Erode) Ltd?
The Stock P/E of Ponni Sugars (Erode) Ltd is 18.0.
What is the Book Value of Ponni Sugars (Erode) Ltd?
The Book Value of Ponni Sugars (Erode) Ltd is 624.
What is the Dividend Yield of Ponni Sugars (Erode) Ltd?
The Dividend Yield of Ponni Sugars (Erode) Ltd is 1.14 %.
What is the ROCE of Ponni Sugars (Erode) Ltd?
The ROCE of Ponni Sugars (Erode) Ltd is 5.18 %.
What is the ROE of Ponni Sugars (Erode) Ltd?
The ROE of Ponni Sugars (Erode) Ltd is 3.56 %.
What is the Face Value of Ponni Sugars (Erode) Ltd?
The Face Value of Ponni Sugars (Erode) Ltd is 10.0.